Prakash Moreshwar Patil

This profile gathers the share dealings of Prakash Moreshwar Patil in Aarti Drugs Limited, where the filings describe the role as chief executive. We count 6 filings; the first trade dates from 18 May 2021 and the latest from 31 March 2022.

No open-market sale appears; the market trades are 5 purchases worth €496k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2022 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €65k. 1 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 1 April 2022, the filings show an open-market purchase worth €262k in Aarti Drugs Limited. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.